Proton MR Spectroscopy of Cortical Tubers in Adults with Tuberous Sclerosis Complex

References

1. ↵
   Hyman MH, Whittemore VH. National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 2000;57:662-664

   CrossRefPubMedWeb of Science
2. ↵
   Barkovich AJ, Kurniecky RI, Dobyns WB, et al. A classification scheme for malformations of cortical development. Neuropediatrics 1996;27:59-63

   CrossRefPubMedWeb of Science
3. ↵
   Nabboutt R, Santos M, Roland Y, et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999;66:370-375

   Abstract/FREE Full Text
4. ↵
   Iwasaki S, Nakagawa H, Kichikawa K, et al. MR and CT of tuberous sclerosis: linear abnormalities in the cerebral white matter. AJNR Am J Neuroradiol 1990;11:1029-1034

   Abstract/FREE Full Text
5. Braffman BH, Bilaniuk LT, Naidich TP, et al. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. Radiology 1992;183:227-238

   PubMedWeb of Science
6. ↵
   Griffiths PD, Bolton P, Verity C. White matter abnormalities in tuberous sclerosis complex. Acta Radiol 1998;39:482-486

   PubMedWeb of Science
7. Yagishita A, Arai N. Cortical tubers without other stigmata of tuberous sclerosis: imaging and pathological findings. Neuroradiology 1999;41:428-432

   CrossRefPubMedWeb of Science
8. ↵
   Baron Y, Barkovich AJ. MR imaging of tuberous sclerosis in neonates and young infants. AJNR Am J Neuroradiol 1999;20:907-916

   Abstract/FREE Full Text
9. Jones AC, Daniells CE, Snell RG, et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 1997;6:2155-2161

   Abstract/FREE Full Text
10. Crino EP, Henske PB. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999;53:1384-1390

    Abstract/FREE Full Text
11. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628

    Abstract/FREE Full Text
12. ↵
    Petroff OAC, Plebam LA, Spencer DD. Symbiosis between in vivo and in vitro nuclear magnetic resonance spectroscopy: the creatine, N–acetyl aspartate, glutamate and GABA content of epileptic human brain. Magn Reson Imaging 1995;13:1197-1211

    CrossRefPubMedWeb of Science
13. ↵
    Sener RN. Infantile tuberous sclerosis changes in the brain: proton MR spectroscopy findings. Comput Med Imag Graph 2000;24:19-24

    CrossRefPubMed
14. ↵
    Li LM, Cendes F, Bastos AC. Neuronal metabolic dysfunction in patients with cortical developmental malformations. Neurology 1998;50:755-759

    Abstract/FREE Full Text
15. ↵
    Aasly J, Silfvenius H, Aas TC, et al. Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res 1999;35:211-217

    CrossRefPubMedWeb of Science
16. ↵
    Hashimoto T, Tayama M, Miyazaki M, et al. Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 1995;37:398-405

    PubMedWeb of Science
17. Tedeschi G, Bertolino A, Campbell G, et al. Reproducibility of proton MR spectroscopic findings. AJNR Am J Neuroradiol 1996;17:1871-1879

    Abstract
18. Chong WK, Paley M, Wilkinson ID, et al. Localized cerebral proton MR spectroscopy in HIV infection and AIDS. AJNR Am J Neuroradiol 1994;15:21-25

    Abstract/FREE Full Text
19. Hugg JW, Laxer KD, Matson GB. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1993;34:788-794

    CrossRefPubMedWeb of Science
20. ↵
    Wilkinson ID, Paley M, Chong WK, et al. Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites. Magn Reson Imaging 1994;12:951-957

    CrossRefPubMedWeb of Science